Exhibiton Event
Jeisys Medical Solidifies Southeast Asian Footprint at ICLAS 2026 in Bangkok, Drawing Intense Interest for ‘DENSITY’ and ‘LinearZ’
BANGKOK, Thailand — Jeisys Medical Inc., a leading global manufacturer of energy-based medical aesthetic devices, announced its successful participation in the International Conference of Laser, Aesthetic and Surgery (ICLAS 2026), held on April 23 in Bangkok, Thailand, marking a significant acceleration in its strategic expansion into the Southeast Asian market.
Jointly hosted by the Korean Association for Laser, Dermatology, And Trichology and the Aesthetic Surgery & Laser Society (ASLS), ICLAS stands as a highly authoritative international academic forum. Bringing together premier medical professionals and industry stakeholders from across Asia under the core slogan “Synergy Beyond Layers: Cellular Signal to Rejuvenation,” the symposium served as a dynamic platform for exchanging clinical breakthroughs.
At this year's conference, Jeisys Medical captured the spotlight by placing its flagship portfolios at the absolute forefront: ‘DENSITY,’ its premium high-frequency radiofrequency (RF) device, and ‘LinearZ,’ its advanced high-intensity focused ultrasound (HIFU) system. The company’s modern exhibition booth, characterized by a sleek silver-toned architecture, effectively projected a sophisticated, high-tech brand identity to international attendees.
To foster deeper engagement on the exhibition floor, Jeisys Medical executed interactive on-site programs, including a digital photo-sharing event. These experiential marketing initiatives allowed the company to seamlessly connect with visiting dermatologists and clinicians, substantially enhancing brand affinity within a highly academic environment.
"ICLAS 2026 provided an exceptional platform to reaffirm the soaring international demand for DENSITY and LinearZ within the rapidly evolving Asian aesthetic sector," said an official spokesperson for Jeisys Medical. "As the global prestige of K-medical aesthetics continues to reach new heights, we will aggressively amplify our brand influence and market share across worldwide medical device channels."
Leveraging the momentum from this international symposium, Jeisys Medical plans to further expand its academic network with global clinicians and continuously reinforce its commercial offensive through customized, localized marketing strategies tailored specifically to Thailand and the broader Southeast Asian markets.
Jointly hosted by the Korean Association for Laser, Dermatology, And Trichology and the Aesthetic Surgery & Laser Society (ASLS), ICLAS stands as a highly authoritative international academic forum. Bringing together premier medical professionals and industry stakeholders from across Asia under the core slogan “Synergy Beyond Layers: Cellular Signal to Rejuvenation,” the symposium served as a dynamic platform for exchanging clinical breakthroughs.
At this year's conference, Jeisys Medical captured the spotlight by placing its flagship portfolios at the absolute forefront: ‘DENSITY,’ its premium high-frequency radiofrequency (RF) device, and ‘LinearZ,’ its advanced high-intensity focused ultrasound (HIFU) system. The company’s modern exhibition booth, characterized by a sleek silver-toned architecture, effectively projected a sophisticated, high-tech brand identity to international attendees.
To foster deeper engagement on the exhibition floor, Jeisys Medical executed interactive on-site programs, including a digital photo-sharing event. These experiential marketing initiatives allowed the company to seamlessly connect with visiting dermatologists and clinicians, substantially enhancing brand affinity within a highly academic environment.
"ICLAS 2026 provided an exceptional platform to reaffirm the soaring international demand for DENSITY and LinearZ within the rapidly evolving Asian aesthetic sector," said an official spokesperson for Jeisys Medical. "As the global prestige of K-medical aesthetics continues to reach new heights, we will aggressively amplify our brand influence and market share across worldwide medical device channels."
Leveraging the momentum from this international symposium, Jeisys Medical plans to further expand its academic network with global clinicians and continuously reinforce its commercial offensive through customized, localized marketing strategies tailored specifically to Thailand and the broader Southeast Asian markets.